Home > Archives for October 2026

Month: October 2026

ThursdayOct 01, 2026 10:50 am

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF; FSE: Z58) Featured in Emerging Growth Research Initiation Report

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF; FSE: Z58), a phosphate exploration company focused on the Murdock Mountain project in northeastern Nevada, is the subject of a company-sponsored initiation report released by Emerging Growth Research (“EGR”). The report reviews the project’s exploration results, proposed physical-processing route, market and delivered-cost considerations, financial position and development milestones. EGR highlights the company’s stated exploration target of 200 million to 220 million tonnes of phosphate-bearing rock and September drilling results that reported grades above 10% P2O5 in…

Continue Reading

ThursdayOct 01, 2026 10:00 am

QualityStocksNewsBreaks – Polymath Research Inc. Collaborates With CineCity Studios to Explore Tokenized Film Investment Platform

Polymath, a provider of enterprise-grade infrastructure for regulated digital securities and tokenized financial instruments, announced a collaboration with CineCity Studios to explore development of a technology-enabled investment platform for film and entertainment investors. Under the proposed structure, Polymath would serve as technology partner for a tokenized film investment vehicle, providing infrastructure for digital securities issuance, investor onboarding, compliance workflows, investor management and administration of tokenized interests. The proposed investment strategy is expected to evaluate opportunities across the film-finance lifecycle and a range of financing structures, with final parameters, structure and offering terms subject to legal, regulatory and commercial review. CineCity…

Continue Reading

ThursdayOct 01, 2026 9:00 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Closes $4 Million Registered Direct Offering

Lantern Pharma (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, announced the closing of its previously announced registered direct offering of 3,669,725 shares of common stock, or pre-funded warrants in lieu thereof, at $1.09 per share. The offering generated approximately $4 million in gross proceeds before fees and expenses. In a concurrent private placement, Lantern issued unregistered warrants to purchase up to 3,669,725 shares at an exercise price of $1.09 per share, potentially providing an additional approximately $4 million in gross proceeds if fully exercised for cash. The company intends…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

QualityStocks is powered by IBNAi

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .